JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.
Skip to content
Study at a glance
Characteristics
Corrigendum
Abstract
Corrigendum to "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis" [Journal of affective disorders, 322 (2023), 194-204].
Create a free account to bookmark articles, vote on relevance, generate your own syntheses, and join the discussion.
Related reading
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
J Affect Disord
October 10, 2025
via PubMed
Corrigendum to “Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis”. [J. Affect. Disord., 322 (2023), 194–204]
Journal of Affective Disorders
January 5, 2024
1 citation
via OpenAlex
Corrigendum to "Psychedelic Assisted Therapy as a Complex Intervention: Implications for clinical trial design".
Therapeutic advances in psychopharmacology
January 1, 2025
via PubMed
Corrigendum to 'Comment on: History repeating: guidelines to address common problems in psychedelic science'.
Therapeutic advances in psychopharmacology
January 1, 2024
via PubMed
Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18–26; doi: 10.1089/psymed.2022.0002
Psychedelic Medicine
May 3, 2024
via OpenAlex
© 2026 Mindscape Collective
Support Our Mission
Choose your preferred way to support Mindscape Collective's work in advancing consciousness research.